Cost of Goods Sold (Annual)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Merit Medical Systems, Inc. (MMSI) had Cost of Goods Sold of $713.18M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$1.36B
Net Income	$120.36M
Cost of Goods Sold	$713.18M
Gross Profit	$643.33M
Operating Expenses	$1.20B
Operating Income	$155.69M
Non-Operating Income/Expense	$-5.70M
Pre-Tax Income	$149.99M
Normalized Pre-Tax Income	$149.99M
Income after Taxes	$120.36M
Income from Continuous Operations	$120.36M
Consolidated Net Income/Loss	$120.36M
Normalized Income after Taxes	$120.36M
EBIT	$155.69M
EBITDA	$277.09M
Weighted-Average Shares Outstanding (Basic)	58.22M
Weighted-Average Shares Outstanding (Diluted)	59.37M
Earnings per Share (EPS) (Basic)	$2.07
Earnings per Share (EPS) (Diluted)	$2.03
Balance Sheet Financials
Current Assets	$923.77M
Property, Plant, and Equipment	$386.17M
Long-Term Assets	$1.49B
Total Assets	$2.42B
Current Liabilities	$216.40M
Long-Term Debt	$729.55M
Long-Term Liabilities	$822.84M
Total Liabilities	$1.04B
Common Equity	$1.38B
Tangible Shareholders Equity	$417.58M
Shareholders Equity	$1.38B
Common Shares Outstanding	58.74M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$220.80M
Cash Flow from Investing Activities	$-368.65M
Cash Flow from Financial Activities	$-60.01M
Beginning Cash	$589.14M
End Cash	$378.77M
Increase/Decrease in Cash	$-210.38M
Stock-Based Compensation	$28.47M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.27
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.35
Debt to Equity Ratio	0.53
Gross Margin	47.43%
Operating Margin	11.48%
EBIT Margin	11.48%
EBITDA Margin	20.43%
Pre-Tax Profit Margin	11.06%
Profit Margin	8.87%
Free Cash Flow	$185.66M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.56
Inventory Turnover	2.33
Receiveable Turnover	6.38
Days Sales in Receivables	57.16
Return on Equity	8.73%
Return on Tangible Equity	28.82%
Return on Assets	4.98%
Return on Investments	5.71%
Book Value Per Share	$23.48
Free Cash Flow per Share	$3.13
Operating Cash Flow per Share	$3.72

Data from Zacks Investment Research, Inc.